Skip to main content

Phase 2 Study Comparing Efficacy and Safety of ABT-165 plus FOLFIRI vs Bevacizumab plus FOLFIRI in Metastatic Colorectal Cancer Previously Treated with Fluoropyrimidine/Oxaliplatin and Bevacizumab

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

AbbVie Inc.

Start Date

May 21, 2018

End Date

March 30, 2021
 

Administered By

Duke Cancer Institute

Awarded By

AbbVie Inc.

Start Date

May 21, 2018

End Date

March 30, 2021